Enzo Life Sciences PD-1 recombinant protein
PD-1 (programmed cell death-1), also known as CD279, is a transmembrane protein important for regulating immune responses. It is a member of the CD28/CTLA-4 family of immunoreceptors and is expressed on T cells and pro-B cells, suggesting it has a broad spectrum of immune regulation. Human recombinant PD-1 is now available from Enzo Life Sciences in 50 µg packs.
PD-1 with its two ligands, PD-L1 and PD-L2, prevent the activation of T cells and protect tissues from autoimmune attack. PD-1 and its ligands are also involved in reduction of infectious immunity, as well as tumour immunity. PD-1 has been shown to facilitate chronic infection and tumour progression. Drugs targeting PD-1 have shown promise in treating cancer and HIV and may be important in a variety of immune-related disorders.
For more information: http://www.enzolifesciences.com/ENZ-PRT190.
Phone: 02 4575 0309
Cayman Chemical Cellular Metabolism Screening Library
Cayman Chemical's Cellular Metabolism Screening Library consists of two plates and contains...
Navinci Diagnostics NaveniFlex Cell Red proximity ligation assay kit
Optimised for cell samples, the kit enables fluorescence visualisation of protein–protein...
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Learn More
I am interested in Enzo Life Sciences PD-1 recombinant protein.
Complete the form and a supplier representative will be in touch.
